Clinical Trial Evidence for Treatment of Depression in Heart Failure

Heart Failure Clinics

Volumn 7, Issue 1, 2011, Pages 81-88

  Echols, Melvin R ^a   Jiang, Wei ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Depression; Depression treatment; Heart failure

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ENCAINIDE; ESCITALOPRAM; FLECAINIDE; FLUOXETINE; IMIPRAMINE; MONOAMINE OXIDASE INHIBITOR; MORACIZINE; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADVERSE DRUG REACTION; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; HEART DISEASE; HEART FAILURE; HUMAN; HYPERTENSIVE CRISIS; ORTHOSTATIC HYPOTENSION; PREVALENCE; PSYCHOTHERAPY; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BIOMEDICAL RESEARCH; DEPRESSION; DISEASE PROGRESSION; EVIDENCE-BASED MEDICINE; HEART FAILURE; HUMANS; PROGNOSIS; PSYCHOTHERAPY; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME; UNITED STATES;

EID: 78649417329     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2010.08.004     Document Type: Review

References (30)

1. Jiang W., Alexander J., Christopher E., et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 2001, 161(15):1849-1856.
2. O'Connor C.M., Jiang W., Kuchibhatla M., et al. Antidepressant use, depression, and survival in patients with heart failure. Arch Intern Med 2008, 168(20):2232-2237.
3. Pozuelo L., Tesar G., Zhang J., et al. Depression and heart disease: what do we know, and where are we headed?. Cleve Clin J Med 2009, 76(1):59-70.
4. Jiang W., Hasselblad V., Krishnan R.R., et al. Patients with CHF and depression have greater risk of mortality and morbidity than patients without depression. J Am Coll Cardiol 2002, 39(5):919-921.
5. Jiang W. Impacts of depression and emotional distress on cardiac disease. Cleve Clin J Med 2008, 75(Suppl 2):S20-S25.
6. Rutledge T., Reis V.A., Linke S.E., et al. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 2006, 48(8):1527-1537.
7. Shapiro P.A. Treatment of depression in patients with congestive heart failure. Heart Fail Rev 2009, 14(1):7-12.
8. Watson K., Summers K.M. Depression in patients with heart failure: clinical implications and management. Pharmacotherapy 2009, 29(1):49-63.
9. O'Connor C.M., Joynt K.E. Depression: are we ignoring an important comorbidity in heart failure?. J Am Coll Cardiol 2004, 43(9):1550-1552.
10. Messerli F.H., Bangalore S., Yao S.S., et al. Cardioprotection with beta-blockers: myths, facts, and Pascal's wager. J Intern Med 2009, 266(3):232-241.
11. Glassman A.H., Johnson L.L., Giardina E.G., et al. The use of imipramine in depressed patients with congestive heart failure. JAMA 1983, 250(15):1997-2001.
12. Glassman A.H., Roose S.P., Bigger J.T. The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered. JAMA 1993, 269(20):2673-2675.
13. Raisfeld I.H. Cardiovascular complications of antidepressant therapy. Interactions at the adrenergic neuron. Am Heart J 1972, 83(1):129-133.
14. Jiang W., Krishnan R.R., O'Connor C.M. Depression and heart disease: evidence of a link, and its therapeutic implications. CNS Drugs 2002, 16(2):111-127.
15. Roose S.P., Glassman A.H., Giardina E.G., et al. Cardiovascular effects of imipramine and bupropion in depressed patients with congestive heart failure. J Clin Psychopharmacol 1987, 7(4):247-251.
16. Roose S.P., Glassman A.H., Giardina E.G., et al. Nortriptyline in depressed patients with left ventricular impairment. JAMA 1986, 256(23):3253-3257.
17. The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992, 327(4):227-233.
18. Echt D.S., Liebson P.R., Mitchell L.B., et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991, 324(12):781-788.
19. Greenberg H.M., Dwyer E.M., Hochman J.S., et al. Interaction of ischaemia and encainide/flecainide treatment: a proposed mechanism for the increased mortality in CAST I. Br Heart J 1995, 74(6):631-635.
20. Roose S.P., Glassman A.H., Attia E., et al. Cardiovascular effects of fluoxetine in depressed patients with heart disease. Am J Psychiatry 1998, 155(5):660-665.
21. Gottlieb S.S., Kop W.J., Thomas S.A., et al. A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure. Am Heart J 2007, 153(5):868-873.
22. Alves T.C., Rays J., Telles R.M., et al. Effects of antidepressant treatment on cognitive performance in elderly subjects with heart failure and comorbid major depression: an exploratory study. Psychosomatics 2007, 48(1):22-30.
23. Jiang W., O'Connor C., Silva S.G., et al. Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure. Am Heart J 2008, 156(3):437-444.
24. Mehra M.R., Rockman H.A., Greenberg B.H. Highlights of the 2008 Scientific Sessions of the Heart Failure Society of America. Toronto, Ontario, Canada, September 20-23, 2008. J Am Coll Cardiol 2009, 53(6):514-522.
25. Angermann C.E., Gelbrich G., Störk S., et al. Rationale and design of a randomised, controlled, multicenter trial investigating the effects of selective serotonin reuptake inhibition on morbidity, mortality, and mood in depressed heart failure patients (MOOD-HF). Eur J Heart Fail 2007, 9(12):1212-1222.
26. Kennedy S.H., Andersen H.F., Thase M.E. Escitalopram in the treatment of major depressive disorder: a meta-analysis. Curr Med Res Opin 2009, 25(1):161-175.
27. Swanson N.A., Burroughs C.C., Long M.A., et al. Controlled trial for smoking cessation in a Navy shipboard population using nicotine patch, sustained-release bupropion, or both. Mil Med 2003, 168(10):830-834.
28. Roose S.P., Dalack G.W., Glassman A.H., et al. Cardiovascular effects of bupropion in depressed patients with heart disease. Am J Psychiatry 1991, 148(4):512-516.
29. Berkman L.F., Blumenthal J., Burg M., et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003, 289(23):3106-3116.
30. Saab P.G., Bang H., Williams R.B., et al. The impact of cognitive behavioral group training on event-free survival in patients with myocardial infarction: the ENRICHD experience. J Psychosom Res 2009, 67(1):45-56.